Expert consensus on management of pathologic myopic tractional maculopathy in China_Chinese Journal of Ocular Fundus Diseases

Authors：

 Fundus Diseases Group in Ophthalmology Branch of Chinese Medical Association ,  Professional Committee of Fundus Diseases in Ophthalmology Branch of Chinese Medical Doctor Association

Corresponding author：

Fundus Diseases Group in Ophthalmology Branch of Chinese Medical Association, Email: lvlin@gzzoc.com; Professional Committee of Fundus Diseases in Ophthalmology Branch of Chinese Medical Doctor Association, Email: dr_lixiaoxin@163.com

Keywords：

Pathologic myopia; Myopic tractional maculopathy; Clinical practice guidelines; Expert consensus

DOI：

10.3760/cma.j.cn511434-20250526-00229

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Pathological myopic tractional maculopathy (MTM), as an important type of macular lesions associated with high myopia, play a significant role in the prevention and treatment of myopic macular diseases. With the rapid development of retinal imaging technologies, especially the widespread application of optical coherence tomography, new technical support has been provided for the accurate diagnosis, clinical staging, treatment decision-making, and long-term follow-up of MTM. However, in clinical practice in China, there are still issues such as unclear definitions, inconsistent staging criteria, and significant differences in treatment strategies. To address these challenges, Fundus Diseases Group in Ophthalmology Branch of Chinese Medical Association and Professional Committee of Fundus Diseases in Ophthalmology Branch of Chinese Medical Doctor Association for Ophthalmologists jointly drafted the Expert consensus on management of pathologic myopic tractional maculopathy in China, based on a systematic literature review and the latest clinical evidence. The consensus was revised multiple times by the core expert group and finally finalized. This consensus systematically establishes a standardized diagnostic and therapeutic system for MTM, covering disease definition and staging, diagnostic pathways and follow-up protocols, treatment strategies based on staging, and surgical intervention plans. It aims to provide ophthalmologists at all levels with a scientifically sound and practically applicable clinical guidance. The development of the consensus strictly adheres to the principles of evidence-based medicine, fully considering the actual clinical conditions of medical institutions at different levels in China. It provides principled recommendations with broad guiding significance for the clinical practice of MTM. It is particularly emphasized that when applying this consensus, clinicians should comprehensively consider the patient’s clinical characteristics, treatment accessibility, and socioeconomic factors, and implement personalized and precise treatment strategies to meet the diverse clinical needs of patients with pathological myopia.

Citation： Fundus Diseases Group in Ophthalmology Branch of Chinese Medical Association, Professional Committee of Fundus Diseases in Ophthalmology Branch of Chinese Medical Doctor Association. Expert consensus on management of pathologic myopic tractional maculopathy in China. Chinese Journal of Ocular Fundus Diseases, 2025, 41(9): 660-674. doi: 10.3760/cma.j.cn511434-20250526-00229 Copy

1.	Wong TY, Ferreira A, Hughes R, et al. Epidemiology and disease burden of pathologic myopia and myopic choroidal neovascularization: an evidence-based systematic review[J]. Am J Ophthalmol, 2014, 157(1): 9-25. DOI: 10.1016/j.ajo.2013.08.010.
2.	Cedrone C, Culasso F, Cesareo M, et al. Incidence of blindness and low vision in a sample population: the Priverno Eye Study, Italy[J]. Ophthalmology, 2003, 110(3): 584-588. DOI: 10.1016/S0161-6420(02)01898-5.
3.	Iwase A, Araie M, Tomidokoro A, et al. Prevalence and causes of low vision and blindness in a Japanese adult population: the Tajimi Study[J]. Ophthalmology, 2006, 113(8): 1354-1362. DOI: 10.1016/j.ophtha.2006.04.022.
4.	Klaver CC, Wolfs RC, Vingerling JR, et al. Age-specific prevalence and causes of blindness and visual impairment in an older population: the Rotterdam Study[J]. Arch Ophthalmol, 1998, 116(5): 653-658. DOI: 10.1001/archopht.116.5.653.
5.	Xu L, Wang Y, Li Y, et al. Causes of blindness and visual impairment in urban and rural areas in Beijing: the Beijing Eye Study[J/OL]. Ophthalmology, 2006, 113(7): 1134[2006-05-02]. https://pubmed.ncbi.nlm.nih.gov/16647133/. DOI: 10.1016/j.ophtha.2006.01.035.
6.	Liu HH, Xu L, Wang YX, et al. Prevalence and progression of myopic retinopathy in Chinese adults: the Beijing Eye Study[J]. Ophthalmology, 2010, 117(9): 1763-1768. DOI: 10.1016/j.ophtha.2010.01.020.
7.	Gao LQ, Liu W, Liang YB, et al. Prevalence and characteristics of myopic retinopathy in a rural Chinese adult population: the Handan Eye Study[J]. Arch Ophthalmol, 2011, 129(9): 1199-1204. DOI: 10.1001/archophthalmol.2011.230.
8.	Ohno-Matsui K, Lai TY, Lai CC, et al. Updates of pathologic myopia[J]. Prog Retin Eye Res, 2016, 52: 156-187. DOI: 10.1016/j.preteyeres.2015.12.001.
9.	Ohno-Matsui K, Kawasaki R, Jonas JB, et al. International photographic classification and grading system for myopic maculopathy[J]. Am J Ophthalmol, 2015, 159(5): 877-883. DOI: 10.1016/j.ajo.2015.01.022.
10.	Ruiz-Medrano J, Montero JA, Flores-Moreno I, et al. Myopic maculopathy: current status and proposal for a new classification and grading system (ATN)[J]. Prog Retin Eye Res, 2019, 69: 80-115. DOI: 10.1016/j.preteyeres.2018.10.005.
11.	Parolini B, Palmieri M, Finzi A, et al. The new myopic traction maculopathy staging system[J]. Eur J Ophthalmol, 2021, 31(3): 1299-1312. DOI: 10.1177/1120672120930590.
12.	Parolini B, Palmieri M, Finzi A, et al. Myopic traction maculopathy: a new perspective on classification and management[J]. Asia Pac J Ophthalmol (Phila), 2021, 10(1): 49-59. DOI: 10.1097/APO.0000000000000347.
13.	Shimada N, Tanaka Y, Tokoro T, et al. Natural course of myopic traction maculopathy and factors associated with progression or resolution[J]. Am J Ophthalmol, 2013, 156(5): 948-957. DOI: 10.1016/j.ajo.2013.06.031.
14.	Parolini B, Palmieri M, Finzi A, et al. Proposal for the management of myopic traction maculopathy based on the new MTM staging system[J]. Eur J Ophthalmol, 2021, 31(6): 3265-3276. DOI: 10.1177/1120672120980943.
15.	Ye H, Tang R, Fang W, et al. Clinical outcomes of posterior scleral reinforcement in Chinese high myopia children[J/OL]. Sci Rep, 2024, 14(1): 16479[2024-07-17]. https://pubmed.ncbi.nlm.nih.gov/39013945/. DOI: 10.1038/s41598-024-67078-7.
16.	Zhang Z, Qi Y, Wei W, et al. Investigation of macular choroidal thickness and blood flow change by optical coherence tomography angiography after posterior scleral reinforcement[J/OL]. Front Med (Lausanne), 2021, 8: 658259[2021-04-29]. https://pubmed.ncbi.nlm.nih.gov/34017847/. DOI: 10.3389/fmed.2021.658259.
17.	Cheong KX, Xu L, Ohno-Matsui K, et al. An evidence-based review of the epidemiology of myopic traction maculopathy[J]. Surv Ophthalmol, 2022, 67(6): 1603-1630. DOI: 10.1016/j.survophthal.2022.03.007.
18.	Gaucher D, Haouchine B, Tadayoni R, et al. Long-term follow-up of high myopic foveoschisis: natural course and surgical outcome[J]. Am J Ophthalmol, 2007, 143(3): 455-462. DOI: 10.1016/j.ajo.2006.10.053.
19.	Ikuno Y, Sayanagi K, Soga K, et al. Foveal anatomical status and surgical results in vitrectomy for myopic foveoschisis[J]. Jpn J Ophthalmol, 2008, 52(4): 269-276. DOI: 10.1007/s10384-008-0544-8.
20.	Kumagai K, Furukawa M, Ogino N, et al. Factors correlated with postoperative visual acuity after vitrectomy and internal limiting membrane peeling for myopic foveoschisis[J]. Retina, 2010, 30(6): 874-880. DOI: 10.1097/IAE.0b013e3181c703fc.
21.	Alkabes M, Burés-Jelstrup A, Salinas C, et al. Macular buckling for previously untreated and recurrent retinal detachment due to high myopic macular hole: a 12-month comparative study[J]. Graefe's Arch Clin Exp Ophthalmol, 2014, 252(4): 571-581. DOI: 10.1007/s00417-013-2497-y.
22.	Alkabes M, Pichi F, Nucci P, et al. Anatomical and visual outcomes in high myopic macular hole (HM-MH) without retinal detachment: a review[J]. Graefe's Arch Clin Exp Ophthalmol, 2014, 252(2): 191-199. DOI: 10.1007/s00417-013-2555-5.
23.	Ando F, Ohba N, Touura K, et al. Anatomical and visual outcomes after episcleral macular buckling compared with those after pars plana vitrectomy for retinal detachment caused by macular hole in highly myopic eyes[J]. Retina, 2007, 27(1): 37-44. DOI: 10.1097/01.iae.0000256660.48993.9e.
24.	Avitabile T, Bonfiglio V, Buccoliero D, et al. Heavy versus standard silicone oil in the management of retinal detachment with macular hole in myopic eyes[J]. Retina, 2011, 31(3): 540-546. DOI: 10.1097/IAE.0b013e3181ec80c7.
25.	Burés-Jelstrup A, Alkabes M, Gómez-Resa M, et al. Visual and anatomical outcome after macular buckling for macular hole with associated foveoschisis in highly myopic eyes[J]. Br J Ophthalmol, 2014, 98(1): 104-109. DOI: 10.1136/bjophthalmol-2013-304016.
26.	Cacciamani A, Lazzeri S, Rossi T et al. Adjustable macular buckling for full-thickness macular hole with foforeschisis in highly myopic eyes: long-term anatomical and functional results[J]. Retina, 2016, 36(4): 709-716. DOI: 10.1097/IAE.0000000000000802.
27.	Caporossi T, Governatori L, Gambini G, et al. Treatment of recurrent high myopic macular hole associated with retinal detachment using a human amniotic membrane[J]. Jpn J Ophthalmol, 2022, 66(6): 518-526. DOI: 10.1007/s10384-022-00953-w.
28.	Chatziralli I, Machairoudia G, Kazantzis D, et al. Inverted internal limiting membrane flap technique for myopic macular hole: a meta-analysis[J]. Surv Ophthalmol, 2021, 66(5): 771-780. DOI: 10.1016/j.survophthal.2021.02.010.
29.	Chen SN, Yang CM. Lens capsular flap transplantation in the management of refractory macular hole from multiple etiologies[J]. Retina, 2016, 36(1): 163-170. DOI: 10.1097/IAE.0000000000000674.
30.	Gao X, Guo J, Meng X, et al. A meta-analysis of vitrectomy with or without internal limiting membrane peeling for macular hole retinal detachment in the highly myopic eyes[J]. BMC Ophthalmol, 2016, 16: 87. DOI: 10.1186/s12886-016-0266-5.
31.	Gürelik İG, Özdemir HB, Acar AB, et al. Descemet's membrane transplantation for the treatment of recurrent high myopic macular hole associated with retinal detachment: Descemet's membrane for myopic macular hole[J]. Graefe's Arch Clin Exp Ophthalmol, 2025, 263(1): 105-110. DOI: 10.1007/s00417-024-06630-7.
32.	Ho TC, Ho A, Chen MS. Vitrectomy with a modified temporal inverted limiting membrane flap to reconstruct the foveolar architecture for macular hole retinal detachment in highly myopic eyes[J/OL]. Acta Ophthalmol, 2018, 96(1): e46-e53[2017-07-05]. https://pubmed.ncbi.nlm.nih.gov/28677833/. DOI: 10.1111/aos.13514.
33.	Jo Y, Ikuno Y, Nishida K. Retinoschisis: a predictive factor in vitrectomy for macular holes without retinal detachment in highly myopic eyes[J]. Br J Ophthalmol, 2012, 96(2): 197-200. DOI: 10.1136/bjo.2011.203232.
34.	Lai CC, Chen YP, Wang NK, et al. Vitrectomy with internal limiting membrane repositioning and autologous blood for macular hole retinal detachment in highly myopic eyes[J]. Ophthalmology, 2015, 122(9): 1889-1898. DOI: 10.1016/j.ophtha.2015.05.040.
35.	Li X, Wang W, Tang S, et al. Gas injection versus vitrectomy with gas for treating retinal detachment owing to macular hole in high myopes[J]. Ophthalmology, 2009, 116(6): 1182-1187. DOI: 10.1016/j.ophtha.2009.01.003.
36.	Luo N, Chen S, Zhao X, et al. Macular buckling combined with vitrectomy and inverted internal limiting membrane flap technique for macular holes with macular retinoschisis without retinal detachment in high myopia[J]. Retina, 2022, 42(11): 2051-2058. DOI: 10.1097/IAE.0000000000003568.
37.	Mete M, Alfano A, Guerriero M, et al. Inverted internal limiting membrane flap technique versus complete internal limiting membrane removal in myopic macular hole surgery: a comparative study[J]. Retina, 2017, 37(10): 1923-1930. DOI: 10.1097/IAE.0000000000001446.
38.	Mura M, Iannetta D, Buschini E, et al. T-shaped macular buckling combined with 25G pars plana vitrectomy for macular hole, macular schisis, and macular detachment in highly myopic eyes[J]. Br J Ophthalmol, 2017, 101(3): 383-388. DOI: 10.1136/bjophthalmol-2015-308124.
39.	Ripandelli G, Coppé AM, Fedeli R, et al. Evaluation of primary surgical procedures for retinal detachment with macular hole in highly myopic eyes: a comparison [corrected] of vitrectomy versus posterior episcleral buckling surgery[J]. Ophthalmology, 2001, 108(12): 2258-2264. DOI: 10.1016/s0161-6420(01)00861-2.
40.	Suda K, Hangai M, Yoshimura N. Axial length and outcomes of macular hole surgery assessed by spectral-domain optical coherence tomography[J]. Am J Ophthalmol, 2011, 151(1): 118-127. DOI: 10.1016/j.ajo.2010.07.007.
41.	Wu TT, Hou TY, Peng KL, et al. Inverted flap technique versus internal limiting membrane insertion for macular hole in eyes with extremely high myopia[J]. BMC Ophthalmol, 2024, 24(1): 286. DOI: 10.1186/s12886-024-03566-8.
42.	Xu Q, Luan J. Vitrectomy with inverted internal limiting membrane flap versus internal limiting membrane peeling for macular hole retinal detachment in high myopia: a systematic review of literature and meta-analysis[J]. Eye (Lond), 2019, 33(10): 1626-1634. DOI: 10.1038/s41433-019-0458-3.
43.	Zhang H, Li Y, Chen G, et al. Human amniotic membrane graft for refractory macular hole: a single-arm meta-analysis and systematic review[J]. J Fr Ophtalmol, 2023, 46(3): 276-286. DOI: 10.1016/j.jfo.2022.07.001.
44.	Zhao X, Li Y, Ma W, et al. Macular buckling versus vitrectomy on macular hole associated macular detachment in eyes with high myopia: a randomised trial[J]. Br J Ophthalmol, 2022, 106(4): 582-586. DOI: 10.1136/bjophthalmol-2020-317800.
45.	Zhao X, Song H, Tanumiharjo S, et al. Macular buckling alone versus combined inverted ILM flap on macular hole-associated macular detachment in patients with high myopia[J]. Eye (Lond), 2023, 37(13): 2730-2735. DOI: 10.1038/s41433-023-02406-1.
46.	Song S, He G, Huang D, et al. Efficacy of pars plana vitrectomy combined with internal limiting membrane peeling and gas tamponade for treating myopic foveoschisis: a meta-analysis[J]. BMC Ophthalmol, 2024, 24(1): 293. DOI: 10.1186/s12886-024-03534-2.
47.	Gui J, Ai L, Huang T. Vitrectomy with or without internal limiting membrane peeling for myopic foveoschisis[J]. BMC Ophthalmol, 2020, 20(1): 83. DOI: 10.1186/s12886-020-01354-8.
48.	Peng KL, Kung YH, Hsu CM, et al. Surgical outcomes of centripetal non-fovea-sparing internal limiting membrane peeling for myopic foveoschisis with and without foveal detachment: a follow-up of at least 3 years[J]. Br J Ophthalmol, 2020, 104(9): 1266-1270. DOI: 10.1136/bjophthalmol-2019-314972.
49.	Qi Y, Yan P, Fan W, et al. Comparison of fovea-sparing and non-internal limiting membrane peeling for retinoschisis with foveal detachment in highly myopic eyes[J]. Eye (Lond), 2021, 35(5): 1467-1472. DOI: 10.1038/s41433-020-1108-5.
50.	Yao Y, Qu J, Shi X, et al. Vitrectomy with silicone oil tamponade and without internal limiting membrane peeling for the treatment of myopic foveoschisis with high risk of macular hole development[J/OL]. Front Med (Lausanne), 2021, 8: 648540[2021-05-28]. https://pubmed.ncbi.nlm.nih.gov/34124090/. DOI: 10.3389/fmed.2021.648540.
51.	Liu B, Chen S, Li Y, et al. Comparison of macular buckling and vitrectomy for the treatment of macular schisis and associated macular detachment in high myopia: a randomized clinical trial[J/OL]. Acta Ophthalmol, 2020, 98(3): e266-e272[2019-11-17]. https://pubmed.ncbi.nlm.nih.gov/31736279/. DOI: 10.1111/aos.14260.
52.	Mateo C, Gómez-Resa MV, Burés-Jelstrup A, et al. Surgical outcomes of macular buckling techniques for macular retinoschisis in highly myopic eyes[J]. Saudi J Ophthalmol, 2013, 27(4): 235-239. DOI: 10.1016/j.sjopt.2013.08.001.
53.	Mateo C, Burés-Jelstrup A, Navarro R, et al. Macular buckling for eyes with myopic foveoschisis secondary to posterior staphyloma[J]. Retina, 2012, 32(6): 1121-1128. DOI: 10.1097/IAE.0b013e31822e5c32.
54.	Quiroz-Reyes MA, Quiroz-Gonzalez EA, Quiroz-Gonzalez MA, et al. Novel surgical approaches for treating myopic traction maculopathy: a meta-analysis[J]. BMC Ophthalmol, 2024, 24(1): 105. DOI: 10.1186/s12886-024-03374-0.
55.	Chen G, Mao S, Tong Y, et al. Fovea sparing versus complete internal limiting membrane peeling for myopic traction maculopathy: a meta-analysis[J]. Int Ophthalmol, 2022, 42(3): 765-773. DOI: 10.1007/s10792-021-02042-2.
56.	Zeng Q, Yao Y, Zhao M. Comparison between fovea-sparing and complete internal limiting membrane peeling for the treatment of myopic traction maculopathy: a systemic review and meta-analysis[J]. Ophthalmic Res, 2021, 64(6): 916-927. DOI: 10.1159/000519021.
57.	Wu J, Xu Q, Luan J. Vitrectomy with fovea-sparing ILM peeling versus total ILM peeling for myopic traction maculopathy: a meta-analysis[J]. Eur J Ophthalmol, 2021, 31(5): 2596-2605. DOI: 10.1177/1120672120970111.
58.	Shimada N, Sugamoto Y, Ogawa M, et al. Fovea-sparing internal limiting membrane peeling for myopic traction maculopathy[J]. Am J Ophthalmol, 2012, 154(4): 693-701. DOI: 10.1016/j.ajo.2012.04.013.
59.	Shiraki N, Wakabayashi T, Ikuno Y, et al. Fovea-sparing versus standard internal limiting membrane peeling for myopic traction maculopathy: a study of 102 consecutive cases[J]. Ophthalmol Retina, 2020, 4(12): 1170-1180. DOI: 10.1016/j.oret.2020.05.016.
60.	Iwasaki M, Miyamoto H, Okushiba U, et al. Fovea-sparing internal limiting membrane peeling versus complete internal limiting membrane peeling for myopic traction maculopathy[J]. Jpn J Ophthalmol, 2020, 64(1): 13-21. DOI: 10.1007/s10384-019-00696-1.
61.	Tian T, Jin H, Zhang Q, et al. Long-term surgical outcomes of multiple parfoveolar curvilinear internal limiting membrane peeling for myopic foveoschisis[J]. Eye (Lond), 2018, 32(11): 1783-1789. DOI: 10.1038/s41433-018-0178-0.
62.	陈秀菊, 罗向东, 孙摇遥, 等. 非内界膜剥除与保留黄斑中心凹内界膜剥除的玻璃体切割术临床疗效比较[J]. 中华实验眼科杂志, 2020, 38(1): 50-54. DOI: 10.3760/cma.j.issn.2095-0160.2020.01.010.Chen XJ, Luo XD, Sun YY, et al. Comparision of the clinical effects on vitrectomy with or without fovea-sparing internal limiting membrane peeling[J]. Chin J Exp Ophthalmol, 2020, 38(1): 50-54. DOI: 10.3760/cma.j.issn.2095-0160.2020.01.010.
63.	Meng B, Zhao L, Yin Y, et al. Internal limiting membrane peeling and gas tamponade for myopic foveoschisis: a systematic review and meta-analysis[J]. BMC Ophthalmol, 2017, 17(1): 166. DOI: 10.1186/s12886-017-0562-8.
64.	Lim SJ, Kwon YH, Kim SH, et al. Vitrectomy and internal limiting membrane peeling without gas tamponade for myopic foveoschisis[J]. Graefe's Arch Clin Exp Ophthalmol, 2012, 250(11): 1573-1577. DOI: 10.1007/s00417-012-1983-y.
65.	Yun LN, Xing YQ. Long-term outcome of highly myopic foveoschisis treated by vitrectomy with or without gas tamponade[J]. Int J Ophthalmol, 2017, 10(9): 1392-1395. DOI: 10.18240/ijo.2017.09.10.
66.	Kim KS, Lee SB, Lee WK. Vitrectomy and internal limiting membrane peeling with and without gas tamponade for myopic foveoschisis[J]. Am J Ophthalmol, 2012, 153(2): 320-326. DOI: 10.1016/j.ajo.2011.07.007.
67.	Zheng B, Chen Y, Chen Y, et al. Vitrectomy and internal limiting membrane peeling with perfluoropropane tamponade or balanced saline solution for myopic foveoschisis[J]. Retina, 2011, 31(4): 692-701. DOI: 10.1097/IAE.0b013e3181f84fc1.
68.	Jiang J, Yu X, He F, et al. Treatment of myopic foveoschisis with air versus perfluoropropane: a retrospective study[J]. Med Sci Monit, 2017, 23: 3345-3352. DOI: 10.12659/msm.901758.
69.	Nakanishi H, Kuriyama S, Saito I, et al. Prognostic factor analysis in pars plana vitrectomy for retinal detachment attributable to macular hole in high myopia: a multicenter study[J]. Am J Ophthalmol, 2008, 146(2): 198-204. DOI: 10.1016/j.ajo.2008.04.022.
70.	Nadal J, Verdaguer P, Canut MI. Treatment of retinal detachment secondary to macular hole in high myopia: vitrectomy with dissection of the inner limiting membrane to the edge of the staphyloma and long-term tamponade[J]. Retina, 2012, 32(8): 1525-1530. DOI: 10.1097/IAE.0b013e3182411cb8.
71.	Meng L, Wei W, Li Y, et al. Treatment of retinal detachment secondary to macular hole in highly myopic eyes: pars plana vitrectomy with internal limiting membrane peel and silicone oil tamponade[J]. Retina, 2014, 34(3): 470-476. DOI: 10.1097/IAE.0b013e31829d004b.
72.	Hong N, Huang BS, Tong JP. Primary silicone oil tamponade and internal limiting membrane peeling for retinal detachment due to macular hole in highly myopic eyes with chorioretinal atrophy[J/OL]. BMC Ophthalmol, 2015, 15: 165[2015-11-11]. https://pubmed.ncbi.nlm.nih.gov/26560878/. DOI: 10.1186/s12886-015-0154-4.
73.	Mancino R, Ciuffoletti E, Martucci A, et al. Anatomical and functional results of macular hole retinal detachment surgery in patients with high myopia and posterior staphyloma treated with perfluoropropane gas or silicone oil[J]. Retina, 2013, 33(3): 586-592. DOI: 10.1097/IAE.0b013e3182670fd7.
74.	温晓英, 杨娜, 张月玲, 等. 高度近视黄斑裂孔性视网膜脱离行玻璃体切割术后C₃F₈与硅油填充的疗效比较[J]. 国际眼科杂志, 2024, 24(5): 805-809. DOI: 10.3980/j.issn.1672-5123.2024.5.27.Wen XY, Yang N, Zhang YL, et al. Efficacy of C₃F₈ versus silicone oil tamponade in highly myopic macular hole retinal detachment[J]. Int Eye Sci, 2024, 24(5): 805-809. DOI: 10.3980/j.issn.1672-5123.2024.5.27.
75.	Ma J, Li H, Ding X, et al. Effectiveness of combined macular buckle under direct vision and vitrectomy with ILM peeling in refractory macular hole retinal detachment with extreme high axial myopia: a 24-month comparative study[J]. Br J Ophthalmol, 2017, 101(10): 1386-1394. DOI: 10.1136/bjophthalmol-2016-310123.
76.	European vitreoretinal update 2016, 16th euretina congress, copenhagen, 2016: abstracts[J]. Ophthalmologica, 2016, 236(Suppl 1): 1-67. DOI: 10.1159/000448911.
77.	Gao Y, Ruan T, Chen N, et al. A comparison of face-down positioning and adjustable positioning after pars plana vitrectomy for macular hole retinal detachment in high myopia[J/OL]. Front Med (Lausanne), 2022, 9: 780475[2022-12-16]. https://pubmed.ncbi.nlm.nih.gov/35252235/. DOI: 10.3389/fmed.2022.780475.
78.	Wang X, Zhu Y, Xu H. Inverted multi-layer internal limiting membrane flap for macular hole retinal detachment in high myopia[J/OL]. Sci Rep, 2022, 12(1): 10593[2022-06-22]. https://pubmed.ncbi.nlm.nih.gov/35732799/. DOI: 10.1038/s41598-022-14716-7.
79.	Nishimura A, Kimura M, Saito Y, et al. Efficacy of primary silicone oil tamponade for the treatment of retinal detachment caused by macular hole in high myopia[J]. Am J Ophthalmol, 2011, 151(1): 148-155. DOI: 10.1016/j.ajo.2010.07.023.

1. Wong TY, Ferreira A, Hughes R, et al. Epidemiology and disease burden of pathologic myopia and myopic choroidal neovascularization: an evidence-based systematic review[J]. Am J Ophthalmol, 2014, 157(1): 9-25. DOI: 10.1016/j.ajo.2013.08.010.
2. Cedrone C, Culasso F, Cesareo M, et al. Incidence of blindness and low vision in a sample population: the Priverno Eye Study, Italy[J]. Ophthalmology, 2003, 110(3): 584-588. DOI: 10.1016/S0161-6420(02)01898-5.
3. Iwase A, Araie M, Tomidokoro A, et al. Prevalence and causes of low vision and blindness in a Japanese adult population: the Tajimi Study[J]. Ophthalmology, 2006, 113(8): 1354-1362. DOI: 10.1016/j.ophtha.2006.04.022.
4. Klaver CC, Wolfs RC, Vingerling JR, et al. Age-specific prevalence and causes of blindness and visual impairment in an older population: the Rotterdam Study[J]. Arch Ophthalmol, 1998, 116(5): 653-658. DOI: 10.1001/archopht.116.5.653.
5. Xu L, Wang Y, Li Y, et al. Causes of blindness and visual impairment in urban and rural areas in Beijing: the Beijing Eye Study[J/OL]. Ophthalmology, 2006, 113(7): 1134[2006-05-02]. https://pubmed.ncbi.nlm.nih.gov/16647133/. DOI: 10.1016/j.ophtha.2006.01.035.
6. Liu HH, Xu L, Wang YX, et al. Prevalence and progression of myopic retinopathy in Chinese adults: the Beijing Eye Study[J]. Ophthalmology, 2010, 117(9): 1763-1768. DOI: 10.1016/j.ophtha.2010.01.020.
7. Gao LQ, Liu W, Liang YB, et al. Prevalence and characteristics of myopic retinopathy in a rural Chinese adult population: the Handan Eye Study[J]. Arch Ophthalmol, 2011, 129(9): 1199-1204. DOI: 10.1001/archophthalmol.2011.230.
8. Ohno-Matsui K, Lai TY, Lai CC, et al. Updates of pathologic myopia[J]. Prog Retin Eye Res, 2016, 52: 156-187. DOI: 10.1016/j.preteyeres.2015.12.001.
9. Ohno-Matsui K, Kawasaki R, Jonas JB, et al. International photographic classification and grading system for myopic maculopathy[J]. Am J Ophthalmol, 2015, 159(5): 877-883. DOI: 10.1016/j.ajo.2015.01.022.
10. Ruiz-Medrano J, Montero JA, Flores-Moreno I, et al. Myopic maculopathy: current status and proposal for a new classification and grading system (ATN)[J]. Prog Retin Eye Res, 2019, 69: 80-115. DOI: 10.1016/j.preteyeres.2018.10.005.
11. Parolini B, Palmieri M, Finzi A, et al. The new myopic traction maculopathy staging system[J]. Eur J Ophthalmol, 2021, 31(3): 1299-1312. DOI: 10.1177/1120672120930590.
12. Parolini B, Palmieri M, Finzi A, et al. Myopic traction maculopathy: a new perspective on classification and management[J]. Asia Pac J Ophthalmol (Phila), 2021, 10(1): 49-59. DOI: 10.1097/APO.0000000000000347.
13. Shimada N, Tanaka Y, Tokoro T, et al. Natural course of myopic traction maculopathy and factors associated with progression or resolution[J]. Am J Ophthalmol, 2013, 156(5): 948-957. DOI: 10.1016/j.ajo.2013.06.031.
14. Parolini B, Palmieri M, Finzi A, et al. Proposal for the management of myopic traction maculopathy based on the new MTM staging system[J]. Eur J Ophthalmol, 2021, 31(6): 3265-3276. DOI: 10.1177/1120672120980943.
15. Ye H, Tang R, Fang W, et al. Clinical outcomes of posterior scleral reinforcement in Chinese high myopia children[J/OL]. Sci Rep, 2024, 14(1): 16479[2024-07-17]. https://pubmed.ncbi.nlm.nih.gov/39013945/. DOI: 10.1038/s41598-024-67078-7.
16. Zhang Z, Qi Y, Wei W, et al. Investigation of macular choroidal thickness and blood flow change by optical coherence tomography angiography after posterior scleral reinforcement[J/OL]. Front Med (Lausanne), 2021, 8: 658259[2021-04-29]. https://pubmed.ncbi.nlm.nih.gov/34017847/. DOI: 10.3389/fmed.2021.658259.
17. Cheong KX, Xu L, Ohno-Matsui K, et al. An evidence-based review of the epidemiology of myopic traction maculopathy[J]. Surv Ophthalmol, 2022, 67(6): 1603-1630. DOI: 10.1016/j.survophthal.2022.03.007.
18. Gaucher D, Haouchine B, Tadayoni R, et al. Long-term follow-up of high myopic foveoschisis: natural course and surgical outcome[J]. Am J Ophthalmol, 2007, 143(3): 455-462. DOI: 10.1016/j.ajo.2006.10.053.
19. Ikuno Y, Sayanagi K, Soga K, et al. Foveal anatomical status and surgical results in vitrectomy for myopic foveoschisis[J]. Jpn J Ophthalmol, 2008, 52(4): 269-276. DOI: 10.1007/s10384-008-0544-8.
20. Kumagai K, Furukawa M, Ogino N, et al. Factors correlated with postoperative visual acuity after vitrectomy and internal limiting membrane peeling for myopic foveoschisis[J]. Retina, 2010, 30(6): 874-880. DOI: 10.1097/IAE.0b013e3181c703fc.
21. Alkabes M, Burés-Jelstrup A, Salinas C, et al. Macular buckling for previously untreated and recurrent retinal detachment due to high myopic macular hole: a 12-month comparative study[J]. Graefe's Arch Clin Exp Ophthalmol, 2014, 252(4): 571-581. DOI: 10.1007/s00417-013-2497-y.
22. Alkabes M, Pichi F, Nucci P, et al. Anatomical and visual outcomes in high myopic macular hole (HM-MH) without retinal detachment: a review[J]. Graefe's Arch Clin Exp Ophthalmol, 2014, 252(2): 191-199. DOI: 10.1007/s00417-013-2555-5.
23. Ando F, Ohba N, Touura K, et al. Anatomical and visual outcomes after episcleral macular buckling compared with those after pars plana vitrectomy for retinal detachment caused by macular hole in highly myopic eyes[J]. Retina, 2007, 27(1): 37-44. DOI: 10.1097/01.iae.0000256660.48993.9e.
24. Avitabile T, Bonfiglio V, Buccoliero D, et al. Heavy versus standard silicone oil in the management of retinal detachment with macular hole in myopic eyes[J]. Retina, 2011, 31(3): 540-546. DOI: 10.1097/IAE.0b013e3181ec80c7.
25. Burés-Jelstrup A, Alkabes M, Gómez-Resa M, et al. Visual and anatomical outcome after macular buckling for macular hole with associated foveoschisis in highly myopic eyes[J]. Br J Ophthalmol, 2014, 98(1): 104-109. DOI: 10.1136/bjophthalmol-2013-304016.
26. Cacciamani A, Lazzeri S, Rossi T et al. Adjustable macular buckling for full-thickness macular hole with foforeschisis in highly myopic eyes: long-term anatomical and functional results[J]. Retina, 2016, 36(4): 709-716. DOI: 10.1097/IAE.0000000000000802.
27. Caporossi T, Governatori L, Gambini G, et al. Treatment of recurrent high myopic macular hole associated with retinal detachment using a human amniotic membrane[J]. Jpn J Ophthalmol, 2022, 66(6): 518-526. DOI: 10.1007/s10384-022-00953-w.
28. Chatziralli I, Machairoudia G, Kazantzis D, et al. Inverted internal limiting membrane flap technique for myopic macular hole: a meta-analysis[J]. Surv Ophthalmol, 2021, 66(5): 771-780. DOI: 10.1016/j.survophthal.2021.02.010.
29. Chen SN, Yang CM. Lens capsular flap transplantation in the management of refractory macular hole from multiple etiologies[J]. Retina, 2016, 36(1): 163-170. DOI: 10.1097/IAE.0000000000000674.
30. Gao X, Guo J, Meng X, et al. A meta-analysis of vitrectomy with or without internal limiting membrane peeling for macular hole retinal detachment in the highly myopic eyes[J]. BMC Ophthalmol, 2016, 16: 87. DOI: 10.1186/s12886-016-0266-5.
31. Gürelik İG, Özdemir HB, Acar AB, et al. Descemet's membrane transplantation for the treatment of recurrent high myopic macular hole associated with retinal detachment: Descemet's membrane for myopic macular hole[J]. Graefe's Arch Clin Exp Ophthalmol, 2025, 263(1): 105-110. DOI: 10.1007/s00417-024-06630-7.
32. Ho TC, Ho A, Chen MS. Vitrectomy with a modified temporal inverted limiting membrane flap to reconstruct the foveolar architecture for macular hole retinal detachment in highly myopic eyes[J/OL]. Acta Ophthalmol, 2018, 96(1): e46-e53[2017-07-05]. https://pubmed.ncbi.nlm.nih.gov/28677833/. DOI: 10.1111/aos.13514.
33. Jo Y, Ikuno Y, Nishida K. Retinoschisis: a predictive factor in vitrectomy for macular holes without retinal detachment in highly myopic eyes[J]. Br J Ophthalmol, 2012, 96(2): 197-200. DOI: 10.1136/bjo.2011.203232.
34. Lai CC, Chen YP, Wang NK, et al. Vitrectomy with internal limiting membrane repositioning and autologous blood for macular hole retinal detachment in highly myopic eyes[J]. Ophthalmology, 2015, 122(9): 1889-1898. DOI: 10.1016/j.ophtha.2015.05.040.
35. Li X, Wang W, Tang S, et al. Gas injection versus vitrectomy with gas for treating retinal detachment owing to macular hole in high myopes[J]. Ophthalmology, 2009, 116(6): 1182-1187. DOI: 10.1016/j.ophtha.2009.01.003.
36. Luo N, Chen S, Zhao X, et al. Macular buckling combined with vitrectomy and inverted internal limiting membrane flap technique for macular holes with macular retinoschisis without retinal detachment in high myopia[J]. Retina, 2022, 42(11): 2051-2058. DOI: 10.1097/IAE.0000000000003568.
37. Mete M, Alfano A, Guerriero M, et al. Inverted internal limiting membrane flap technique versus complete internal limiting membrane removal in myopic macular hole surgery: a comparative study[J]. Retina, 2017, 37(10): 1923-1930. DOI: 10.1097/IAE.0000000000001446.
38. Mura M, Iannetta D, Buschini E, et al. T-shaped macular buckling combined with 25G pars plana vitrectomy for macular hole, macular schisis, and macular detachment in highly myopic eyes[J]. Br J Ophthalmol, 2017, 101(3): 383-388. DOI: 10.1136/bjophthalmol-2015-308124.
39. Ripandelli G, Coppé AM, Fedeli R, et al. Evaluation of primary surgical procedures for retinal detachment with macular hole in highly myopic eyes: a comparison [corrected] of vitrectomy versus posterior episcleral buckling surgery[J]. Ophthalmology, 2001, 108(12): 2258-2264. DOI: 10.1016/s0161-6420(01)00861-2.
40. Suda K, Hangai M, Yoshimura N. Axial length and outcomes of macular hole surgery assessed by spectral-domain optical coherence tomography[J]. Am J Ophthalmol, 2011, 151(1): 118-127. DOI: 10.1016/j.ajo.2010.07.007.
41. Wu TT, Hou TY, Peng KL, et al. Inverted flap technique versus internal limiting membrane insertion for macular hole in eyes with extremely high myopia[J]. BMC Ophthalmol, 2024, 24(1): 286. DOI: 10.1186/s12886-024-03566-8.
42. Xu Q, Luan J. Vitrectomy with inverted internal limiting membrane flap versus internal limiting membrane peeling for macular hole retinal detachment in high myopia: a systematic review of literature and meta-analysis[J]. Eye (Lond), 2019, 33(10): 1626-1634. DOI: 10.1038/s41433-019-0458-3.
43. Zhang H, Li Y, Chen G, et al. Human amniotic membrane graft for refractory macular hole: a single-arm meta-analysis and systematic review[J]. J Fr Ophtalmol, 2023, 46(3): 276-286. DOI: 10.1016/j.jfo.2022.07.001.
44. Zhao X, Li Y, Ma W, et al. Macular buckling versus vitrectomy on macular hole associated macular detachment in eyes with high myopia: a randomised trial[J]. Br J Ophthalmol, 2022, 106(4): 582-586. DOI: 10.1136/bjophthalmol-2020-317800.
45. Zhao X, Song H, Tanumiharjo S, et al. Macular buckling alone versus combined inverted ILM flap on macular hole-associated macular detachment in patients with high myopia[J]. Eye (Lond), 2023, 37(13): 2730-2735. DOI: 10.1038/s41433-023-02406-1.
46. Song S, He G, Huang D, et al. Efficacy of pars plana vitrectomy combined with internal limiting membrane peeling and gas tamponade for treating myopic foveoschisis: a meta-analysis[J]. BMC Ophthalmol, 2024, 24(1): 293. DOI: 10.1186/s12886-024-03534-2.
47. Gui J, Ai L, Huang T. Vitrectomy with or without internal limiting membrane peeling for myopic foveoschisis[J]. BMC Ophthalmol, 2020, 20(1): 83. DOI: 10.1186/s12886-020-01354-8.
48. Peng KL, Kung YH, Hsu CM, et al. Surgical outcomes of centripetal non-fovea-sparing internal limiting membrane peeling for myopic foveoschisis with and without foveal detachment: a follow-up of at least 3 years[J]. Br J Ophthalmol, 2020, 104(9): 1266-1270. DOI: 10.1136/bjophthalmol-2019-314972.
49. Qi Y, Yan P, Fan W, et al. Comparison of fovea-sparing and non-internal limiting membrane peeling for retinoschisis with foveal detachment in highly myopic eyes[J]. Eye (Lond), 2021, 35(5): 1467-1472. DOI: 10.1038/s41433-020-1108-5.
50. Yao Y, Qu J, Shi X, et al. Vitrectomy with silicone oil tamponade and without internal limiting membrane peeling for the treatment of myopic foveoschisis with high risk of macular hole development[J/OL]. Front Med (Lausanne), 2021, 8: 648540[2021-05-28]. https://pubmed.ncbi.nlm.nih.gov/34124090/. DOI: 10.3389/fmed.2021.648540.
51. Liu B, Chen S, Li Y, et al. Comparison of macular buckling and vitrectomy for the treatment of macular schisis and associated macular detachment in high myopia: a randomized clinical trial[J/OL]. Acta Ophthalmol, 2020, 98(3): e266-e272[2019-11-17]. https://pubmed.ncbi.nlm.nih.gov/31736279/. DOI: 10.1111/aos.14260.
52. Mateo C, Gómez-Resa MV, Burés-Jelstrup A, et al. Surgical outcomes of macular buckling techniques for macular retinoschisis in highly myopic eyes[J]. Saudi J Ophthalmol, 2013, 27(4): 235-239. DOI: 10.1016/j.sjopt.2013.08.001.
53. Mateo C, Burés-Jelstrup A, Navarro R, et al. Macular buckling for eyes with myopic foveoschisis secondary to posterior staphyloma[J]. Retina, 2012, 32(6): 1121-1128. DOI: 10.1097/IAE.0b013e31822e5c32.
54. Quiroz-Reyes MA, Quiroz-Gonzalez EA, Quiroz-Gonzalez MA, et al. Novel surgical approaches for treating myopic traction maculopathy: a meta-analysis[J]. BMC Ophthalmol, 2024, 24(1): 105. DOI: 10.1186/s12886-024-03374-0.
55. Chen G, Mao S, Tong Y, et al. Fovea sparing versus complete internal limiting membrane peeling for myopic traction maculopathy: a meta-analysis[J]. Int Ophthalmol, 2022, 42(3): 765-773. DOI: 10.1007/s10792-021-02042-2.
56. Zeng Q, Yao Y, Zhao M. Comparison between fovea-sparing and complete internal limiting membrane peeling for the treatment of myopic traction maculopathy: a systemic review and meta-analysis[J]. Ophthalmic Res, 2021, 64(6): 916-927. DOI: 10.1159/000519021.
57. Wu J, Xu Q, Luan J. Vitrectomy with fovea-sparing ILM peeling versus total ILM peeling for myopic traction maculopathy: a meta-analysis[J]. Eur J Ophthalmol, 2021, 31(5): 2596-2605. DOI: 10.1177/1120672120970111.
58. Shimada N, Sugamoto Y, Ogawa M, et al. Fovea-sparing internal limiting membrane peeling for myopic traction maculopathy[J]. Am J Ophthalmol, 2012, 154(4): 693-701. DOI: 10.1016/j.ajo.2012.04.013.
59. Shiraki N, Wakabayashi T, Ikuno Y, et al. Fovea-sparing versus standard internal limiting membrane peeling for myopic traction maculopathy: a study of 102 consecutive cases[J]. Ophthalmol Retina, 2020, 4(12): 1170-1180. DOI: 10.1016/j.oret.2020.05.016.
60. Iwasaki M, Miyamoto H, Okushiba U, et al. Fovea-sparing internal limiting membrane peeling versus complete internal limiting membrane peeling for myopic traction maculopathy[J]. Jpn J Ophthalmol, 2020, 64(1): 13-21. DOI: 10.1007/s10384-019-00696-1.
61. Tian T, Jin H, Zhang Q, et al. Long-term surgical outcomes of multiple parfoveolar curvilinear internal limiting membrane peeling for myopic foveoschisis[J]. Eye (Lond), 2018, 32(11): 1783-1789. DOI: 10.1038/s41433-018-0178-0.
62. 陈秀菊, 罗向东, 孙摇遥, 等. 非内界膜剥除与保留黄斑中心凹内界膜剥除的玻璃体切割术临床疗效比较[J]. 中华实验眼科杂志, 2020, 38(1): 50-54. DOI: 10.3760/cma.j.issn.2095-0160.2020.01.010.Chen XJ, Luo XD, Sun YY, et al. Comparision of the clinical effects on vitrectomy with or without fovea-sparing internal limiting membrane peeling[J]. Chin J Exp Ophthalmol, 2020, 38(1): 50-54. DOI: 10.3760/cma.j.issn.2095-0160.2020.01.010.
63. Meng B, Zhao L, Yin Y, et al. Internal limiting membrane peeling and gas tamponade for myopic foveoschisis: a systematic review and meta-analysis[J]. BMC Ophthalmol, 2017, 17(1): 166. DOI: 10.1186/s12886-017-0562-8.
64. Lim SJ, Kwon YH, Kim SH, et al. Vitrectomy and internal limiting membrane peeling without gas tamponade for myopic foveoschisis[J]. Graefe's Arch Clin Exp Ophthalmol, 2012, 250(11): 1573-1577. DOI: 10.1007/s00417-012-1983-y.
65. Yun LN, Xing YQ. Long-term outcome of highly myopic foveoschisis treated by vitrectomy with or without gas tamponade[J]. Int J Ophthalmol, 2017, 10(9): 1392-1395. DOI: 10.18240/ijo.2017.09.10.
66. Kim KS, Lee SB, Lee WK. Vitrectomy and internal limiting membrane peeling with and without gas tamponade for myopic foveoschisis[J]. Am J Ophthalmol, 2012, 153(2): 320-326. DOI: 10.1016/j.ajo.2011.07.007.
67. Zheng B, Chen Y, Chen Y, et al. Vitrectomy and internal limiting membrane peeling with perfluoropropane tamponade or balanced saline solution for myopic foveoschisis[J]. Retina, 2011, 31(4): 692-701. DOI: 10.1097/IAE.0b013e3181f84fc1.
68. Jiang J, Yu X, He F, et al. Treatment of myopic foveoschisis with air versus perfluoropropane: a retrospective study[J]. Med Sci Monit, 2017, 23: 3345-3352. DOI: 10.12659/msm.901758.
69. Nakanishi H, Kuriyama S, Saito I, et al. Prognostic factor analysis in pars plana vitrectomy for retinal detachment attributable to macular hole in high myopia: a multicenter study[J]. Am J Ophthalmol, 2008, 146(2): 198-204. DOI: 10.1016/j.ajo.2008.04.022.
70. Nadal J, Verdaguer P, Canut MI. Treatment of retinal detachment secondary to macular hole in high myopia: vitrectomy with dissection of the inner limiting membrane to the edge of the staphyloma and long-term tamponade[J]. Retina, 2012, 32(8): 1525-1530. DOI: 10.1097/IAE.0b013e3182411cb8.
71. Meng L, Wei W, Li Y, et al. Treatment of retinal detachment secondary to macular hole in highly myopic eyes: pars plana vitrectomy with internal limiting membrane peel and silicone oil tamponade[J]. Retina, 2014, 34(3): 470-476. DOI: 10.1097/IAE.0b013e31829d004b.
72. Hong N, Huang BS, Tong JP. Primary silicone oil tamponade and internal limiting membrane peeling for retinal detachment due to macular hole in highly myopic eyes with chorioretinal atrophy[J/OL]. BMC Ophthalmol, 2015, 15: 165[2015-11-11]. https://pubmed.ncbi.nlm.nih.gov/26560878/. DOI: 10.1186/s12886-015-0154-4.
73. Mancino R, Ciuffoletti E, Martucci A, et al. Anatomical and functional results of macular hole retinal detachment surgery in patients with high myopia and posterior staphyloma treated with perfluoropropane gas or silicone oil[J]. Retina, 2013, 33(3): 586-592. DOI: 10.1097/IAE.0b013e3182670fd7.
74. 温晓英, 杨娜, 张月玲, 等. 高度近视黄斑裂孔性视网膜脱离行玻璃体切割术后C₃F₈与硅油填充的疗效比较[J]. 国际眼科杂志, 2024, 24(5): 805-809. DOI: 10.3980/j.issn.1672-5123.2024.5.27.Wen XY, Yang N, Zhang YL, et al. Efficacy of C₃F₈ versus silicone oil tamponade in highly myopic macular hole retinal detachment[J]. Int Eye Sci, 2024, 24(5): 805-809. DOI: 10.3980/j.issn.1672-5123.2024.5.27.
75. Ma J, Li H, Ding X, et al. Effectiveness of combined macular buckle under direct vision and vitrectomy with ILM peeling in refractory macular hole retinal detachment with extreme high axial myopia: a 24-month comparative study[J]. Br J Ophthalmol, 2017, 101(10): 1386-1394. DOI: 10.1136/bjophthalmol-2016-310123.
76. European vitreoretinal update 2016, 16th euretina congress, copenhagen, 2016: abstracts[J]. Ophthalmologica, 2016, 236(Suppl 1): 1-67. DOI: 10.1159/000448911.
77. Gao Y, Ruan T, Chen N, et al. A comparison of face-down positioning and adjustable positioning after pars plana vitrectomy for macular hole retinal detachment in high myopia[J/OL]. Front Med (Lausanne), 2022, 9: 780475[2022-12-16]. https://pubmed.ncbi.nlm.nih.gov/35252235/. DOI: 10.3389/fmed.2022.780475.
78. Wang X, Zhu Y, Xu H. Inverted multi-layer internal limiting membrane flap for macular hole retinal detachment in high myopia[J/OL]. Sci Rep, 2022, 12(1): 10593[2022-06-22]. https://pubmed.ncbi.nlm.nih.gov/35732799/. DOI: 10.1038/s41598-022-14716-7.
79. Nishimura A, Kimura M, Saito Y, et al. Efficacy of primary silicone oil tamponade for the treatment of retinal detachment caused by macular hole in high myopia[J]. Am J Ophthalmol, 2011, 151(1): 148-155. DOI: 10.1016/j.ajo.2010.07.023.

Next Article
Interpretation of Expert consensus on clinical diagnosis and treatment of sterile intraocular inflammation secondary to intraocular drug delivery (2025)

Chinese Journal of Ocular Fundus Diseases

Expert consensus on management of pathologic myopic tractional maculopathy in China

Abstract Full text Figures/Tables Video References Cited by

Next Article

Format

Content